Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Progression of kidney disease in Indigenous Australians: the eGFR follow-up study
Author: Maple-Brown, L.
Hughes, J.
Ritte, R.
Barzi, F.
Hoy, W.
Lawton, P.
Jones, G.
Death, E.
Simmonds, A.
Sinha, A.
Cherian, S.
Thomas, M.
McDermott, R.
Brown, A.
O Dea, K.
Jerums, G.
Cass, A.
Macisaac, R.
Citation: Clinical Journal of the American Society of Nephrology, 2016; 11(6):993-1004
Publisher: American Society of Nephrology
Issue Date: 2016
ISSN: 1555-9041
Statement of
Louise J. Maple-Brown, Jaquelyne T. Hughes, Rebecca Ritte, Federica Barzi, Wendy E. Hoy, Paul D. Lawton, Graham R.D. Jones, Elizabeth Death, Alison Simmonds, Ashim K. Sinha, Sajiv Cherian, Mark A.B. Thomas, Robyn McDermott, Alex D.H. Brown, Kerin O’Dea, George Jerums, Alan Cass, and Richard J. MacIsaac
Abstract: Background and objectives: Indigenous Australians experience a heavy burden of CKD. To address this burden, the eGFR Follow-Up Study recruited and followed an Indigenous Australian cohort from regions of Australia with the greatest ESRD burden. We sought to better understand factors contributing to the progression of kidney disease. Specific objectives were to assess rates of progression of eGFR in Indigenous Australians with and without CKD and identify factors associated with a decline in eGFR. Design, setting, participants, & measurements: This observational longitudinal study of Indigenous Australian adults was conducted in >20 sites. The baseline cohort was recruited from community and primary care clinic sites across five strata of health, diabetes status, and kidney function. Participants were then invited to follow up at 2-4 years; if unavailable, vital status, progression to RRT, and serum creatinine were obtained from medical records. Primary outcomes were annual eGFR change and combined renal outcome (first of ≥30% eGFR decline with follow-up eGFR<60 ml/min per 1.73 m(2), progression to RRT, or renal death). Results: Participants (n=550) were followed for a median of 3.0 years. Baseline and follow-up eGFR (geometric mean [95% confidence interval], 83.9 (80.7 to 87.3) and 70.1 (65.9 to 74.5) ml/min per 1.73 m(2), respectively. Overall mean annual eGFR change was -3.1 (-3.6 to -2.5) ml/min per 1.73 m(2). Stratified by baseline eGFR (≥90, 60-89, <60 ml/min per 1.73 m(2)), annual eGFR changes were -3.0 (-3.6 to -2.4), -1.9 (-3.3 to -0.5), and -5.0 (-6.5 to -3.6) ml/min per 1.73 m(2). Across baseline eGFR categories, annual eGFR decline was greatest among adults with baseline albumin-to-creatinine ratio (ACR) >265 mg/g (30 mg/mmol). Baseline determinants of the combined renal outcome (experienced by 66 participants) were higher urine ACR, diabetes, lower measured GFR, and higher C-reactive protein. Conclusions: The observed eGFR decline was three times higher than described in nonindigenous populations. ACR was confirmed as a powerful predictor for eGFR decline across diverse geographic regions.
Keywords: Chronic kidney disese; follow-up studies
Rights: Copyright © 2016 by the American Society of Nephrology
RMID: 0030077537
DOI: 10.2215/CJN.09770915
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.